GnRH agonist could be responsible for cardiovascular toxicity not only through indirect mechanism, in which hypogonadism plays a critical role in the onset of metabolic syndrome, but also through the direct mechanism due to possible presence of GnRH receptors on the heart leading to lower cardiac contractility [47]. Here, GNRH1 is linked to metabolic syndrome.